Drug Therapy Problems among Patients with both Cardiovascular Diseases and Diabetes Mellitus in a Sub-Saharan African Referral Hospital
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2021, Vol 5, Issue 1
Abstract
Background: Patients with both type 2 diabetes mellitus and cardiovascular disease receive multiple medications but there are limited studies on drug therapy problems among them in Sub-Saharan Africa. Objective: To determine the predictors of drug therapy problems among adult patients with both type 2 diabetes and cardiovascular diseases. Setting: Kenyatta National Hospital. Method: A cross-sectional study involving 180 adult patients with both comorbidities was conducted. Data collected included sociodemographic and clinical characteristics, medications prescribed and drug therapy problems. Data was analyzed using STATA v.13 at p<0.05. Main outcome measures: Drug therapy problems and their predictors. Results: Majority (91.1%) of the patients had at least one drug therapy problems; most common being untreated indication, 87 (48.3%) which was significantly associated with furosemide use (p=0.003) and >72 months living with diabetes (p=0.007). Non-adherence was associated with the perception of disease control or cure (p<0.001). Under dosing of medications was significant in poor glycemic control (=<0.001) and poor blood pressure control (p=0.012). Conclusion: Clinicians should be aware that patients with both comorbidities are more likely to be under dosed, non-adhere to treatment or have other untreated conditions. Recommendation for Practice • Health care practitioners need to continuously monitor the drug therapy problems among patients with comorbidities • Prescribers should holistically manage patients specifically by identification of untreated conditions • Diabetic hypertensive patients who are not responding to treatment should always be assessed for under dosing and nonadherence • Kenyatta National Hospital should be encouraged to have counseling programs, especially to patients with long standing comorbidities, to improve adherence.
Authors and Affiliations
Mugane GN*, Ndemo F and Nyamu D
Keywords
Related Articles
- EP ID EP748550
- DOI 10.23880/oajpr-16000232
- Views 102
- Downloads 0
Yeast as Biotechnological Tool in Food Industry
Yeasts are widely spread in nature. Fermentation of sugars by yeast is the oldest and largest application of this technology. Many types of yeasts are used for making many foods: baker’s yeast in bread production, brewe...
Mini Review on Research of T.W. Hermann as an Honorable Editor
I have initiated my research at the Department of Pharmaceutical Chemistry of Poznan University of Medical Sciences in 1960 on stability of drugs. According to my knowledge at that time I have been the first to discover...
Pharmaceutical Applications of White Button Mushroom (Agaricus Bisporus)
In this review paper, characteristics of Agaricus bisporus and its applications medicine were described. Agaricus bisporus is targeted by humans foraging for food and have many usages in human dietary followed by pharma...
Advances in Anticancer & Marine Drug Research An Overview
Out of earth’s total surface area, more than 70% is covered with marine/salty water. World oldest, most revered & holy texts, the Vedas, term the Ocean as ‘Ratnakar’, or the bestower of immense riches. From times immemor...
Preparation and Characterization of Sodium Alginate- Eudragit E100 Based Systems with Prospective Pharmaceutical Delivery to Application
Regarding the preparation of a local drug delivery system, the possibility of incorporating an active substance in a matrix system was investigated to prolong the drug release. A complex between sodium alginate and a tr...